A clinical trial is a research study that tests an investigational medicine or therapy in people to help us understand how well it works and how safe it is. Clinical trials contribute to the advancement of medicine with the goal of making life […]
Read more »ECHO is proud to announce our participation in the Revolution clinical trial (Apex-103) for solid tumors including pancreatic cancer, non-small cell lung cancer, and colorectal cancer. This groundbreaking national study has recently gained national attention for its encouraging early results […]
Read more »Peripheral neuropathy happens when the nerves that are located outside of the brain and spinal cord (peripheral nerves) are damaged. Peripheral neuropathy is a common side effect of many types of chemotherapy. The condition leads to tingling, burning, weakness, or numbness, most commonly […]
Read more »Dr. Curis joined the ECHO research team in October 2024. He attended the University of Rhode Island for his undergraduate bachelor’s degree in Biological and Health Sciences. He then attended Avalon University School of Medicine for his medical doctorate. He […]
Read more »Research is a core focus at Eastern Connecticut Hematology & Oncology (ECHO). For over 35 years, we have excelled at bringing the latest advancements and treatments to patients across Eastern Connecticut. This includes offering our patients the possibility to participate in promising […]
Read more »Beigene’s CELESTIAL Trial This clinical trial is for patients who have experienced progression of chronic lymphocytic leukemia. The usual first line treatment includes a BTK inhibitor (ibrutinib, acalabrutinib, zanubrutinib , pirtoburtinib) or the combination of venetoclax with obinutuzumab. Some patients […]
Read more »The Beigene’s CELESTIAL clinical trial for chronic lymphocytic leukemia This clinical trial is for patients who have experienced progression of chronic lymphocytic leukemia. The usual first line treatment includes a BTK inhibitor (ibrutinib, acalabrutinib, zanubrutinib , pirtoburtinib) or the combination […]
Read more »Below is information on the INTerpath 009 study which is a clinical trial for early-stage non-small cell lung cancer (NSCLC). This clinical trial is trying to determine if an investigational study drug combination, when given after initial treatment and surgery, […]
Read more »A Phase 3 randomized double-blind study of adjuvant pembrolizumab with or without V940 in participants with resectable Stage II to IIIB (N 2) non-small cell lung cancer who are not achieving pCR after receiving neoadjuvant pembolizumab with platinum-based doublet chemotherapy […]
Read more »Chronic Lymphocytic Leukemia (CLL) is a cancer that affects the blood and bone marrow, specifically the white blood cells called lymphocytes. CLL is a chronic leukemia, meaning it develops slowly and can progress slowly over months or years. It is one of the […]
Read more »
